NDC properties for NDC 9 0591-2475
NDC item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
NDC item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
NDC item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
NDC item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
NDC item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
NDC item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
NDC item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |